Michael Dunn MD, FRCPC

Dr. Michael Dunn is a Senior Neonatologist working in the Women and Babies Program at Sunnybrook Health Sciences Centre and a Professor in the Department of Paediatrics at the University of Toronto. He was Chief of the Department of Newborn and Developmental Paediatrics at Sunnybrook from 2001 – 2009. He is an established researcher who has helped spearhead a number of large randomized trials examining the effect of neonatal therapies. He has a longstanding interest in the respiratory management of preterm infants and performed a number of early clinical trials to evaluate surfactant replacement therapy. He has been very involved in the activities of several collaborative neonatal networks including the Canadian Neonatal Network (CNN) and the Vermont Oxford Network (VON).

Dr. Dunn was the Clinical Leader for the “Resuscitation and Stabilization” group of the VON Neonatal Quality Improvement Collaborative in 2009 and recently served for seven years as a Clinical Expert for NICU teams focusing on improving outcomes for Micropremature infants (those born at less than 26 weeks gestation) and their families.

Dr. Dunn serves or has served on several local, national and international bodies committed to improving the quality of neonatal-perinatal care. He was a longstanding member of the Maternal and Perinatal Death Review Committee to the Chief Coroner for the Province of Ontario. He is a past president of the Neonatal-Perinatal Section of the Canadian Paediatric Society (CPS) and was a member of the Consensus Committee to Establish Recommended Standards for Newborn ICU Design. He is committed to the provision of quality care to NICU patients and their families and believes that we as health care providers need to do everything in our power to give our newest citizens the best possible start in life.